Similarly, JAG1-MSC treatment further decreased inflammatory mediators, whereas Notch2 silence abolished the beneficial effect of JAG1-MSCs on APAP-induced liver inflammation (Fig. 2C). The gene discussed is JAG1; the disease is Hepatitis.